The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2003, Volume 27, Issue 9

The study presented in this article used a controlled-porosity osmotic pump, which was prepared in the form of a bilayered tablet containing a drug compartment and an osmogen layer for the delayed release of diltiazem HCI.

Related Content:

Drug DeliveryDevelopmentFormulation and Drug Delivery, Solid DosagePharmaceutical Technology-09-02-2003
Moderna and Generation Bio Announce Strategic Collaboration
Curia and Corning Collaborate to Advance Biopharmaceutical Continuous-Flow Development
BioNTech and OncoC4 to Co-Develop mAb for Solid Tumor Indications